Injective (INJ) is currently priced at $3.22, reflecting a slight decline of 0.40% over the past 24 hours. The asset's daily trading range has been narrow, with a high of $3.27 and a low of $3.21, indicating reduced volatility during this period.

Trading volume stands at approximately 34.4 million, contributing to a volume-to-market cap ratio of 10.69%, suggesting moderate liquidity in the market. The hourly moving averages show a downward trend, with the 8, 13, and 21 SMA all exhibiting negative percentages, while the 144 SMA is gaining at +3.10%, indicating potential short-term bearish sentiment tempered by longer-term bullish signals.

The 1-hour Relative Strength Index (RSI) is at 48, which suggests a neutral stance, while the 7-day RSI at 56 indicates a slight bullish momentum over a longer timeframe. Price changes over the last 7 days (+9.96%) and 14 days (+3.40%) suggest that INJ has been gaining ground, although the 30-day change is modest at +1.55%.

Despite the current price being significantly lower than its all-time high of $52.62, the recent price action shows that INJ has maintained a relatively stable performance with positive short to medium-term trends. This stability, coupled with the high volume and moderate RSI levels, implies that there could be potential for upward movement in the near future.

Given the current technical indicators and the broader market sentiment, the recommendation for Injective (INJ) is to Hold. While there is bullish momentum in the longer-term RSI and price changes, the immediate technical indicators show mixed signals, suggesting caution before initiating new positions.